EAS CLA Clinical Trials and Studies

EAS CLA Information

EAS CLA Clinical Trials and Studies

In a recent Norwegian CLA study (not specific to EAS CLA) involving 60 overweight men and women followed for 12 weeks, subjects taking CLA lost an average of six pounds of body fat compared to subjects taking a placebo. As in other recent studies, CLA resulted not in actual weight loss but in improved body composition reducing body fat while preserving muscle mass.

A one-year continuation of the original 12-month, double-blind, placebo-controlled study of 180 overweight subjects, showed that CLA supplementation stopped weight regain, preventing subjects from regaining the 8 percent of body fat they lost in the first year and there were no CLA side effects - and 4 Your Health BioSculpt Extreme chief active ingredient is CLA.

EAS CLA Information